Quanex Building Products Corporation — FY2020 Form 10-K
Reporting period: Fiscal year ended October 31, 2020. The filing also presents unaudited fourth-quarter results. Quanex manufactures fenestration and cabinet components for building-products OEMs, principally in North America and the U.K., with additional operations in Germany.
Key financial results
| Metric | FY2020 | FY2019 |
|---|---|---|
| Net sales | $851.6 million | $893.8 million |
| Operating income (loss) | $55.3 million | $(26.4) million |
| Net income (loss) | $38.5 million | $(46.7) million |
| Diluted EPS | $1.17 | $(1.42) |
| Cash provided by operating activities | $100.8 million | $96.4 million |
| Capital expenditures | $25.7 million | $24.9 million |
| Cash and cash equivalents at year-end | $51.6 million | $30.9 million |
| Long-term debt, excluding current portion | $116.7 million | $156.4 million |
- Sales declined 5% year over year. Operating margin was approximately 6.5% in FY2020; FY2019 included a $74.6 million goodwill impairment charge.
- Fourth-quarter FY2020 sales were $255.4 million, operating income was $27.8 million, net income was $22.2 million, and diluted EPS was $0.68. Fourth-quarter FY2019 included an operating loss of $23.7 million and net loss of $30.9 million.
- Cash flows from investing activities were $(25.2) million and financing activities were $(55.1) million. Financing outflows included $40.5 million of net debt repayments, $10.5 million of dividends, and $7.2 million of share repurchases.
Business performance and changes
- North American Fenestration sales decreased 4% to $483.4 million; operating income was essentially flat at $39.9 million.
- European Fenestration sales decreased 2% to $161.1 million; operating income rose 6% to $20.1 million.
- North American Cabinet Components sales declined 8% to $210.1 million, reflecting lower volumes—including customer strategic shifts and COVID-19 effects—and lower pricing. The segment recorded a $2.5 million operating loss, versus a $74.2 million loss in FY2019, which included the goodwill impairment.
- Lower sales volumes, including pandemic-related impacts, were partly offset by cost reductions, pricing and surcharges. Lower interest rates and debt outstanding reduced interest expense to $5.2 million from $9.6 million.
Liquidity, debt and capital
- At year-end, Quanex had $51.6 million of cash, $103.0 million drawn on its revolving credit facility, $4.8 million of letters of credit and $15.3 million of finance lease obligations. Reported availability under the $325 million revolving facility was $217.2 million.
- The facility matures in October 2023. Quanex reported compliance with its financial covenants at October 31, 2020; covenants include minimum interest coverage of 2.25:1 and maximum leverage of 3.25:1.
- Management said cash, operating cash flow and available borrowing capacity should be adequate for anticipated working capital, capital expenditure, dividend and debt-service needs. The annual dividend declared was $0.32 per share.
Outlook, risks and unusual items
- Management did not provide company-specific quantified earnings or revenue guidance. It cited third-party forecasts: U.S. housing starts of about 1.4 million in calendar 2020, 1.3 million in 2021 and 1.4 million in 2022; window shipments and semi-custom cabinet demand were expected to recover in 2021 after 2020 declines. Management noted some sales planned for FY2020 might occur in FY2021 or FY2022.
- COVID-19 disrupted operations and demand: U.K. plants temporarily shut in spring 2020, while U.S. and German facilities remained operational. All facilities were operating at fiscal year-end. The duration and financial effects of the pandemic remained uncertain; capital expenditure plans had been reduced by approximately 25%–30% during the year.
- Brexit-related uncertainty includes possible changes in U.K. raw-material availability, pricing and tariffs. U.K. operations represented approximately 15% of FY2020 sales.
- Other principal risks include cyclical and seasonal housing demand, customer concentration and pricing leverage, raw-material cost and supply volatility, foreign exchange and interest-rate exposure, covenant restrictions, product and warranty claims, and potential future goodwill or other asset impairment. One customer contributed more than 10% of FY2020 consolidated sales.
- Quanex continued to defend claims alleging defects in a commercial sealant product sold in the 2000s. The ultimate outcome was not determinable; no accrual was recorded, and management believed the claims would not materially affect the company. Fiscal 2020 inventory reserves rose to $6.5 million from $3.8 million.
- The company adopted lease accounting guidance in FY2020, adding approximately $39.3 million of lease liabilities and $38.9 million of right-of-use assets at adoption; management reported no material effect on income or cash flows. No goodwill impairment was recorded in FY2020, although the North American Cabinet Components reporting unit’s fair value exceeded carrying value by only about 5% in the annual test.
Important facts for investors to verify
- Whether post-year-end demand, customer order patterns and housing-market conditions support the anticipated recovery, particularly in cabinet components.
- Whether the North American Cabinet Components reporting unit maintains or improves its narrow 5% goodwill valuation cushion.
- Current borrowing, covenant headroom and liquidity availability under the revolving facility, including the effects of variable interest rates.
- Developments in commercial sealant litigation, insurance coverage and any resulting accruals or cash costs.
- Whether pandemic-related supply, operating and customer-credit risks, Brexit effects and higher inventory reserves change materially.
The auditor issued an unqualified opinion on the FY2020 financial statements and on internal control over financial reporting.